Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation and emerging growth company, filed this Form 8-K on March 15, 2018, reporting events occurring between March 2, 2018, and April 12, 2018.
Key Financial Metrics
This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on equity transactions.
Material Changes
The company reported significant unregistered sales of equity securities under Item 3.02:
- Note Conversions: Issued 144,585,823 shares upon conversion of outstanding notes.
- Warrant Exercises: Issued 92,023,304 shares upon cashless exercise of outstanding warrants.
- Total Issuance: 236,609,127 shares issued during the period.
- Exemption: Transactions were conducted pursuant to Section 3(a)(9) of the Securities Act of 1933.
- Post-Issuance Capitalization: As of April 12, 2018, the company had 480,035,712 shares of common stock outstanding.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the disclosure of the equity issuances.
Investor Verification Checklist
- Verify the terms of the outstanding notes and warrants that were converted or exercised.
- Confirm the dilution impact of the 236,609,127 new shares on existing shareholders.
- Review the company's latest 10-K or 10-Q for financial context, as this 8-K contains no financial performance data.
- Check for any subsequent filings regarding the use of proceeds or further capitalization changes.